01 2Thalomid
02 3Thalomid
Main Therapeutic Indication : Skin Disorder
Currency : USD
2015 Revenue in Millions : 221
2014 Revenue in Millions : 185
Growth (%) : -16%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 132
2016 Revenue in Millions : 152
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 152
2015 Revenue in Millions : 185
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 114
2017 Revenue in Millions : 132
Growth (%) : -14%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 71
2018 Revenue in Millions : 89
Growth (%) : -20
LOOKING FOR A SUPPLIER?